{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:35:34Z","timestamp":1791178534508,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00223-011-9501-5","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T06:36:30Z","timestamp":1307082990000},"page":"140-150","source":"Crossref","is-referenced-by-count":143,"title":["Fibroblast Growth Factor 23 (FGF23) and Alpha-Klotho Stimulate Osteoblastic MC3T3.E1 Cell Proliferation and Inhibit Mineralization"],"prefix":"10.1007","volume":"89","author":[{"given":"V.","family":"Shalhoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Renshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. G.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,3]]},"reference":[{"key":"9501_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) Fgf-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"9501_CR2","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","volume":"145","author":"X Bai","year":"2004","unstructured":"Bai X, Miao D, Li J, Goltzman D, Karaplis AC (2004) Transgenic mice overexpressing human fibroblast growth factor 23 (r176q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145:5269\u20135279","journal-title":"Endocrinology"},{"key":"9501_CR3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","volume":"67","author":"JJ Kazama","year":"2005","unstructured":"Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M (2005) Pretreatment serum fgf-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 67:1120\u20131125","journal-title":"Kidney Int"},{"key":"9501_CR4","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of fgf-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272\u20132279","journal-title":"Kidney Int"},{"key":"9501_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of fgf23 demonstrates an essential physiological role of fgf23 in phosphate and vitamin d metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"9501_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2004) Fgf-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314:409\u2013414","journal-title":"Biochem Biophys Res Commun"},{"key":"9501_CR7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","volume":"18","author":"TJ Weber","year":"2003","unstructured":"Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum fgf23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227\u20131234","journal-title":"J Bone Miner Res"},{"key":"9501_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"KE White","year":"2000","unstructured":"White KE, Evans WE, O\u2019Riordan JLH, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"9501_CR9","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"9501_CR10","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of fgf23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"9501_CR11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of dmp1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310\u20131315","journal-title":"Nat Genet"},{"key":"9501_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An fgf23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385\u2013390","journal-title":"Hum Mol Genet"},{"key":"9501_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) Fgf-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"9501_CR14","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 299:F882\u2013F889","journal-title":"Am J Physiol Renal Physiol"},{"issue":"Suppl 2","key":"9501_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","volume":"36","author":"SM Moe","year":"2006","unstructured":"Moe SM (2006) Vascular calcification and renal osteodystrophy relationship in chronic kidney disease. Eur J Clin Invest 36(Suppl 2):51\u201362","journal-title":"Eur J Clin Invest"},{"key":"9501_CR16","doi-asserted-by":"crossref","first-page":"p59","DOI":"10.1159\/000210389","volume":"111","author":"F Saji","year":"2009","unstructured":"Saji F, Shiizaki K, Shimada S, Okada T, Kunimoto K, Sakaguchi T, Hatamura I, Shigematsu T (2009) Regulation of fibroblast growth factor 23 production in bone in uremic rats. Nephron Physiol 111:p59\u2013p66","journal-title":"Nephron Physiol"},{"key":"9501_CR17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","volume":"95","author":"T Shimada","year":"2010","unstructured":"Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Juppner H (2010) Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 95:578\u2013585","journal-title":"J Clin Endocrinol Metab"},{"key":"9501_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","volume":"342","author":"N Itoh","year":"2010","unstructured":"Itoh N (2010) Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 342:1\u201311","journal-title":"Cell Tissue Res"},{"key":"9501_CR19","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","volume":"146","author":"X Yu","year":"2005","unstructured":"Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE (2005) Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146:4647\u20134656","journal-title":"Endocrinology"},{"key":"9501_CR20","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"key":"9501_CR21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical fgf receptor into a specific receptor for fgf23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"9501_CR22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","volume":"20","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, Davis SI, Summers LJ, White KE (2009) Initial fgf23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20:955\u2013960","journal-title":"J Am Soc Nephrol"},{"key":"9501_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351","journal-title":"Nature"},{"key":"9501_CR24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2010.73","volume":"77","author":"CL Huang","year":"2010","unstructured":"Huang CL (2010) Regulation of ion channels by secreted klotho: mechanisms and implications. Kidney Int 77:855\u2013860","journal-title":"Kidney Int"},{"key":"9501_CR25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23:939\u2013948","journal-title":"J Bone Miner Res"},{"key":"9501_CR26","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","volume":"277","author":"T Yamashita","year":"2002","unstructured":"Yamashita T, Konishi M, Miyake A, Inui K, Itoh N (2002) Fibroblast growth factor (fgf)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 277:28265\u201328270","journal-title":"J Biol Chem"},{"key":"9501_CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/08977199009108277","volume":"3","author":"CH Kasperk","year":"1990","unstructured":"Kasperk CH, Wergedal JE, Mohan S, Long DL, Lau KH, Baylink DJ (1990) Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors 3:147\u2013158","journal-title":"Growth Factors"},{"key":"9501_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/03008208909023898","volume":"20","author":"SB Rodan","year":"1989","unstructured":"Rodan SB, Wesolowski G, Thomas KA, Yoon K, Rodan GA (1989) Effects of acidic and basic fibroblast growth factors on osteoblastic cells. Connect Tissue Res 20:283\u2013288","journal-title":"Connect Tissue Res"},{"key":"9501_CR29","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jcb.20007","volume":"91","author":"HJ Hausser","year":"2004","unstructured":"Hausser HJ, Brenner RE (2004) Low doses and high doses of heparin have different effects on osteoblast-like saos-2 cells in vitro. J Cell Biochem 91:1062\u20131073","journal-title":"J Cell Biochem"},{"key":"9501_CR30","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","volume":"24","author":"MC Hu","year":"2010","unstructured":"Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438\u20133450","journal-title":"FASEB J"},{"key":"9501_CR31","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM (2010) Circulating levels of soluble klotho and fgf23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95:E352\u2013E357","journal-title":"J Clin Endocrinol Metab"},{"key":"9501_CR32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbrc.2010.06.110","volume":"398","author":"Y Yamazaki","year":"2010","unstructured":"Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y (2010) Establishment of sandwich elisa for soluble alpha-klotho measurement: age-dependent change of soluble alpha-klotho levels in healthy subjects. Biochem Biophys Res Commun 398:513\u2013518","journal-title":"Biochem Biophys Res Commun"},{"key":"9501_CR33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","volume":"78","author":"MC Hu","year":"2010","unstructured":"Hu MC, Shi M, Zhang J, Quinones H, Kuro-o M, Moe OW (2010) Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 78:1240\u20131251","journal-title":"Kidney Int"},{"key":"9501_CR34","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1242\/dev.127.9.1845","volume":"127","author":"DP Rice","year":"2000","unstructured":"Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I (2000) Integration of fgf and twist in calvarial bone and suture development. Development 127:1845\u20131855","journal-title":"Development"},{"key":"9501_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jcp.20813","volume":"210","author":"RA Jackson","year":"2007","unstructured":"Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nurcombe V, Cool SM (2007) Heparan sulfate regulates the anabolic activity of mc3t3-e1 preosteoblast cells by induction of runx2. J Cell Physiol 210:38\u201350","journal-title":"J Cell Physiol"},{"key":"9501_CR36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1359\/jbmr.1998.13.4.645","volume":"13","author":"F Debiais","year":"1998","unstructured":"Debiais F, Hott M, Graulet AM, Marie PJ (1998) The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res 13:645\u2013654","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00223-011-9501-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T13:47:05Z","timestamp":1637761625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-011-9501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["9501"],"URL":"https:\/\/doi.org\/10.1007\/s00223-011-9501-5","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,3]]}}}